| Symbol | BLUWW |
|---|---|
| Name | BLUE WATER ACQUISITION CORP. III |
| Sector | UNDEFINED |
| Region | North America |
| Industry | Blank Checks |
| Address | 15 E. PUTNAM AVENUE,SUITE 363, GREENWICH, Connecticut, 06830, United States |
| Telephone | +1 646 303-0737 |
| Fax | — |
| — | |
| Website | — |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | — |
| Description | Clarus Therapeutics, Inc. is a mens specialty pharmaceutical company with a mission to help men with hypogonadism, a condition associated with a deficiency or absence of endogenous testosterone. We are working hard every day to make a difference in the lives of affected men. As a privately-held company, Clarus Therapeutics is backed by Thomas, McNerney & Partners, L.P., H.I.G. BioHealth Partners, ProQuest Investments, C-Bridge Capital Partners, LLC, BVCF Management, Ltd. and Pavilion Capital Pte Ltd. To learn more, visit clarustherapeutics.com. Additional info from NASDAQ: |
New Form 10-K - Blue Water Acquisition Corp. III <b>Filed:</b> 2026-04-14 <b>AccNo:</b> 0001104659-26-043320 <b>Size:</b> 6 MB
Read moreNew Form NT 10-K - Blue Water Acquisition Corp. III <b>Filed:</b> 2026-03-31 <b>AccNo:</b> 0001104659-26-037683 <b>Size:</b> 25 KB
Read more